118 related articles for article (PubMed ID: 36453189)
21. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
22. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
[TBL] [Abstract][Full Text] [Related]
23. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
[TBL] [Abstract][Full Text] [Related]
24. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer.
Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N
J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
26. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.
Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT
J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131
[TBL] [Abstract][Full Text] [Related]
27. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
28. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
[TBL] [Abstract][Full Text] [Related]
30. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
[TBL] [Abstract][Full Text] [Related]
31. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
32. [Study of the risk factors for ovarian metastasis in patients with endometrial carcinoma].
Li LY; Zeng SY; Wan L; Ao MH
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):352-5. PubMed ID: 18953868
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
34. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis.
Ilhan TT; Kebapcilar A; Yilmaz SA; Ilhan T; Kerimoglu OS; Pekin AT; Akyurek F; Unlu A; Celik C
Asian Pac J Cancer Prev; 2015; 16(11):4503-8. PubMed ID: 26107194
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma.
Teng F; Zhang YF; Wang YM; Yu J; Lang X; Tian WY; Jiang CX; Xue FX
Acta Obstet Gynecol Scand; 2015 Mar; 94(3):266-73. PubMed ID: 25545203
[TBL] [Abstract][Full Text] [Related]
36. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
38. Novel preoperative predictive score to evaluate lymphovascular space involvement in endometrial cancer: an aid to the sentinel lymph node algorithm.
Capozzi VA; Sozzi G; Uccella S; Ceni V; Cianciolo A; Gambino G; Armano G; Pugliese M; Scambia G; Chiantera V; Berretta R
Int J Gynecol Cancer; 2020 Jun; 30(6):806-812. PubMed ID: 32284322
[TBL] [Abstract][Full Text] [Related]
39. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
40. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
Lu H; Li J; Wang L; Zhou H; Liu Y; Wang D; Lin Z
Med Sci Monit; 2016 Feb; 22():408-14. PubMed ID: 26852916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
